Botulinum toxin A for the Treatment of Keloids

Skin Pharmacology and Physiology

Volumn 25, Issue 6, 2012, Pages 313-318

  Gauglitz, G G ^a   Bureik, D ^a   Dombrowski, Y ^a   Pavicic, T ^a   Ruzicka, T ^a   Schauber, J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Botulinum toxin A; Fibroblasts; Keloids; Treatment

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BOTULINUM TOXIN A; COLLAGEN TYPE 1; COLLAGEN TYPE 1A1; COLLAGEN TYPE 1A2; COLLAGEN TYPE 3; COLLAGEN TYPE 3A1; FIBRONECTIN; FIBRONECTIN 1; LAMININ; LAMININ BETA2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CELL CULTURE; CELL METABOLISM; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; KELOID; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTINS; BOTULINUM TOXINS, TYPE A; CELL PROLIFERATION; COLLAGEN; FEMALE; FIBROBLASTS; FIBRONECTINS; HUMANS; INJECTIONS, INTRALESIONAL; KELOID; LAMININ; MALE; TRANSFORMING GROWTH FACTOR BETA;

EID: 84865584193     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000342125     Document Type: Article

References (18)

1. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG: Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies. Mol Med 2011; 17: 113-125.
2. Brown JJ, Bayat A: Genetic susceptibility to raised dermal scarring. Br J Dermatol 2009; 161: 8-18.
3. Sund B: New Developments in Wound Care. London, PJB, 2000.
4. Young VL, Hutchinson J: Insights into patient and clinician concerns about scarring. Plastic Reconstr Surg 2009; 124: 256-265.
5. Lee BJ, Jeong JH, Wang SG, Lee JC, Goh EK, Kim HW: Effect of botulinum toxin type a on a rat surgical wound model. Clin Exp Otorhinolaryngol 2009; 2: 20-27.
6. Viera MH, Amini S, Valins W, Berman B: Innovative therapies in the treatment of keloids and hypertrophic scars. J Clin Aesthet Dermatol 2010; 3: 20-26.
7. Gassner HG, Brissett AE, Otley CC, Boahene DK, Boggust AJ, Weaver AL, et al: Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled study. Mayo Clin Proc 2006; 81: 1023-1028. (Pubitemid 44175012)
8. Zhibo X, Miaobo Z: Intralesional botulinum toxin type A injection as a new treatment measure for keloids. Plast Reconstr Surg 2009; 124: 275e-277e.
9. Xiao Z, Zhang F, Lin W, Zhang M, Liu Y: Effect of botulinum toxin type A on transforming growth factor beta1 in fibroblasts derived from hypertrophic scar: A preliminary report. Aesthetic Plast Surg 2010; 34: 424-427.
10. Gauglitz GG: Therapeutic strategies for the improvement of scars. PRIME 2012; 2: 16-27.
11. Xiao Z, Zhang F, Cui Z: Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: A preliminary report. Aesthetic Plast Surg 2009; 33: 409-412.
12. Friedman PM, Skover GR, Payonk G, Kauvar AN, Geronemus RG: 3D in-vivo optical skin imaging for topographical quantitative assessment of non-ablative laser technology. Dermatol Surg 2002; 28: 199-204. (Pubitemid 34259743)
13. Gauglitz GG, Kunte C: Recommendations for the prevention and therapy of hypertrophic scars and keloids. Hautarzt 2011; 62: 337-346.
14. Gauglitz GG, Pavicic T, Ruzicka T: Management of hypertrophic scars and keloids. MMW Fortschr Med 2010; 152: 40-43, quiz 44.
15. Butler PD, Longaker MT, Yang GP: Current progress in keloid research and treatment. J Am Coll Surg 2008; 206: 731-741.
16. Kose O, Waseem A: Keloids and hypertrophic scars: Are they two different sides of the same coin? Dermatol Surg 2008; 34: 336-346. (Pubitemid 351316825)
17. Szulgit G, Rudolph R, Wandel A, Tenenhaus M, Panos R, Gardner H: Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars. J Invest Dermatol 2002; 118: 409-415. (Pubitemid 34227156)
18. Bock O, Yu H, Zitron S, Bayat A, Ferguson MW, Mrowietz U: Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta Derm Venereol 2005; 85: 216-220. (Pubitemid 40695163)